Enter your login e-mail to the account
Search
Search parameters
Search results
- Consequences of genitourinary malignancies therapy on cardiovascular system
Prof. MUDr. Beata Mladosievičová, CSc., MUDr. Lucia Petríková, RNDr. Zuzana Poljak Valášková, Ph.D.
(5/2018, Review articles )
- Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - Current position of vinorelbine within complex breast cancer treatment
MUDr. Silvia Jurišová, MUDr. Miroslava Malejčíková
(6/2016, Drugs & drug classes ) - Publikujeme v zahraničí
(2/2012, Information & comments ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Third line treatment in a patient over 60 years of age with the refractory/relapsed aggressive B-non Hodgkin’s lymphoma type DLBCL
MUDr. Radoslav Greksák, PhD.
(6/2020, Case reports ) - Cardiotoxicity of drugs used in adjuvant therapy of breast cancer
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Katarína Ševčíková
(2/2009, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Olaratumab – liečba pre pacientov s pokročilým sarkómom mäkkých tkanív nevhodných na chirurgickú liečbu alebo rádioterapiu
MUDr. Peter Zuzák
(3/2018, Drugs & drug classes ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - Long-term response and remission with pixantrone in 4th line treatment in patient with relapsed/refractory diffuse large B-cell non-Hodgkin lymphoma
MUDr. Radoslav Greksák, PhD.
(1/2020, Case reports ) - Treatment of diffuse large cell non-Hodgkin›s lymphoma in the geriatric population – are we doing things differently?
MUDr. Jana Tabišová
(1/2024, Main topic ) - Neoadjuvant therapy of triple-negative breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(4/2020, Review articles ) - Pharmacological and non-pharmacological possibilities of antracycline and trastuzumab cardiotoxicity risk reduction
MUDr. Zuzana Országhová Jr., MUDr. Ľubica Harvanová, PhD., Prof. MUDr. Beata Mladosievičová, CSc.
(4/2020, Review articles ) - The role of biomarkers in cardiotoxicity detection in childhood cancer survivors
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Dagmar Urbanová
(4/2010, Original articles & case reports ) - Zaujímavosti z literatúry - ESMO usmernenia pre klinickú prax: príprava, realizácia a šírenie. Editoriál
doc. MUDr. Peter Beržinec, CSc.
(4/2010, Information & comments )